carvedilol has been researched along with oxybutynin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aggarwal, A; Agrawal, SS | 1 |
| Bhalekar, MR; Kshirsagar, SJ; Mohapatra, SK | 1 |
| Kesavan, BR; Palagati, S; Selvaraj, BR; Sridhar, SK | 1 |
1 review(s) available for carvedilol and oxybutynin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for carvedilol and oxybutynin
| Article | Year |
|---|---|
Randomised, cross-over, comparative bioavailability trial of matrix type transdermal drug delivery system (TDDS) of carvedilol and hydrochlorothiazide combination in healthy human volunteers: a pilot study.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antihypertensive Agents; Area Under Curve; Biological Availability; Carbazoles; Carvedilol; Cross-Over Studies; Drug Combinations; Drug Eruptions; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Pilot Projects; Propanolamines; Transdermal Patch; Young Adult | 2010 |
4 other study(ies) available for carvedilol and oxybutynin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
Topics: Administration, Cutaneous; Animals; Antihypertensive Agents; Biological Availability; Carbazoles; Carvedilol; Drug Delivery Systems; Male; Propanolamines; Rats; Rats, Wistar; Skin Absorption; Transdermal Patch | 2012 |
Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
Topics: Adrenergic beta-Antagonists; Animals; Biological Availability; Blood Pressure; Carvedilol; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Liberation; Kinetics; Liposomes; Male; Models, Animal; Models, Statistical; Nanostructures; Particle Size; Permeability; Rats; Rats, Wistar; Skin Absorption; Solubility; Transdermal Patch | 2020 |